[1]
Nakkash, R.I.A. 2026. Optimal Target Level of Glycosylated Hemoglobin (HbA1c) for Reducing Cardiovascular Mortality in Patients with Diabetic Nephropathy: A Systematic Review. American Journal of Medical Science and Innovation. 5, 1 (Jan. 2026), 40–51. DOI:https://doi.org/10.54536/ajmsi.v5i1.6467.